Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
46
INKT Quote, Financials, Valuation and Earnings
Last price:
$25.32
Seasonality move
:
-10.47%
Day range:
$23.11 - $30.64
52-week range:
$4.56 - $76.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
885.5K
Avg. volume:
1.9M
1-year change:
122.23%
Market cap:
$92.1M
Revenue:
--
EPS (TTM):
-$2.56
Earnings Data
Next earnings date for INKT
Aug 13
2025
Most recent earnings per share
-$0.70
Missed by $0.09
(May 15/2025)
Consensus Estimate
-$0.61
(May 15/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
INKT Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | -- | -- | -- | -$0.45 | -- |
| 08/13/2025 | Q2 | -- | -- | -- | -$0.46 | -- |
| 05/15/2025 | Q1 | -- | -- | -$0.70 | -$0.61 | -$0.09 |
| 03/18/2025 | Q4 | -- | -- | -$0.66 | -$0.50 | -$0.16 |
| 11/14/2024 | Q3 | -- | -- | -$0.50 | -$0.80 | $0.30 |
| 08/13/2024 | Q2 | -- | -- | -$0.70 | -$0.97 | $0.27 |
| 05/14/2024 | Q1 | -- | -- | -$1.10 | -$1.53 | $0.43 |
| 03/21/2024 | Q4 | -- | -- | -$1.54 | -$1.53 | -$0.01 |
| 11/09/2023 | Q3 | -- | -- | -$1.50 | -$1.83 | $0.33 |
| 08/10/2023 | Q2 | -- | -- | -$1.80 | -$1.98 | $0.18 |
| 05/11/2023 | Q1 | -- | -- | -$1.70 | -- | -- |
| 03/21/2023 | Q4 | -- | -- | -$2.30 | -- | -- |
| 11/03/2022 | Q3 | -- | -- | -$1.90 | -- | -- |
| 08/09/2022 | Q2 | -- | -- | -$1.80 | -- | -- |
| 05/10/2022 | Q1 | -- | -- | -$2.30 | -- | -- |
| 03/18/2022 | Q4 | -- | -- | -$1.72 | -- | -- |
| 11/29/2021 | Q3 | -- | -- | -$4.34 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$2.23 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$1.35 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.54 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$2.13 | -- | -- |
MiNK Therapeutics Earnings Questions
-
How Much did MiNK Therapeutics Generate in Revenue Last Quarter?
MiNK Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did MiNK Therapeutics Beat Earnings Last Quarter?
MiNK Therapeutics announced earnings per share of -$0.70 which represents a miss of analyst forecast a -$0.61 per share.
-
Is MiNK Therapeutics Profitable?
MiNK Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for MiNK Therapeutics EPS Next Year?
MiNK Therapeutics's earnings are forecast to decrease from -$2.86 per share to -$2.67 per share next year representing a decrease of -30.94%.
-
When is MiNK Therapeutics's Earnings Date?
MiNK Therapeutics's next earnings date is August 13, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 3.64% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 2.15% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.87% over the past day.
